Self-sampling for Non-attenders to Cervical Cancer Screening
- Age
- 30 – 65
- Sex
- Female
- Study type
- Interventional
- Purpose
- Screening
- Participants needed
- 15,000 (estimated)
- Sponsor
- The Institute of Molecular and Translational Medicine, Czech Republic · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThe trial will evaluate whether self-sampling and human papillomavirus (HPV) testing may increase cervical cancer screening attendance among under-screened women in Czech Republic. Different ways of offering self-sampling device will be evaluated.
Loading trial locations…